Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Geoffrey Porges
Pharma
BMS, Amgen and Pfizer face steepest patent cliffs
Thanks to expected quick erosion after exclusivity losses, the three firms will face the biggest impact among 19 large Western biopharmas.
Angus Liu
Dec 29, 2021 9:56am
Large pharmas will have $1.7T M&A firepower next year: analyst
Dec 1, 2021 11:05am
Pharma's quarterly earnings shows lots of growth despite COVID
Aug 11, 2021 11:30am
Analyst counters FTC's arguments for stricter pharma M&A reviews
Apr 26, 2021 10:20am
Drug pricing threat gets real for pharma
Mar 26, 2021 8:08am
Sanofi, Regeneron's Libtayo goes after Keytruda in lung cancer
Feb 23, 2021 10:05am
